In the pursuit of countering postoperative nausea and vomiting (PONV) among bariatric surgery patients, researchers integrated low-dose haloperidol into enhanced recovery protocols. Analyzing data from 475 patients, they found that those who received haloperidol had lower rates of PONV, required fewer additional antiemetics, and experienced significantly shorter hospital stays. This innovative approach not only eases patient discomfort but also enhances recovery, promoting safe discharge within 24 hours of bariatric surgery.
Journal Article by Lam P, Druar N (…) Shetty S et 2 al. in Surg Endosc
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.